ATE254131T1 - Benzimidazolderivate - Google Patents

Benzimidazolderivate

Info

Publication number
ATE254131T1
ATE254131T1 AT98904273T AT98904273T ATE254131T1 AT E254131 T1 ATE254131 T1 AT E254131T1 AT 98904273 T AT98904273 T AT 98904273T AT 98904273 T AT98904273 T AT 98904273T AT E254131 T1 ATE254131 T1 AT E254131T1
Authority
AT
Austria
Prior art keywords
8alkyl
14aryl
6alkynyl
6alkenyl
hydrogen
Prior art date
Application number
AT98904273T
Other languages
English (en)
Inventor
Jeffrey H Tidwell
Stanley Dawes Chamberlain
George Andrew Freeman
Joseph Howing Chan
George Walter Koszalka
Leroy Townsend
John Drach
Original Assignee
Glaxo Group Ltd
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9703134.8A external-priority patent/GB9703134D0/en
Application filed by Glaxo Group Ltd, Univ Michigan filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE254131T1 publication Critical patent/ATE254131T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Insulated Conductors (AREA)
AT98904273T 1997-02-13 1998-02-13 Benzimidazolderivate ATE254131T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3799297P 1997-02-13 1997-02-13
GBGB9703134.8A GB9703134D0 (en) 1997-02-14 1997-02-14 Benzimidazole derivates
PCT/GB1998/000448 WO1998035977A1 (en) 1997-02-13 1998-02-13 Benzimidazole derivatives

Publications (1)

Publication Number Publication Date
ATE254131T1 true ATE254131T1 (de) 2003-11-15

Family

ID=26311002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98904273T ATE254131T1 (de) 1997-02-13 1998-02-13 Benzimidazolderivate

Country Status (8)

Country Link
US (1) US6413938B1 (de)
EP (1) EP0970100B1 (de)
JP (1) JP2001512453A (de)
AT (1) ATE254131T1 (de)
AU (1) AU6221998A (de)
CA (1) CA2280761A1 (de)
DE (1) DE69819695D1 (de)
WO (1) WO1998035977A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707185A (pt) 1996-01-23 1999-03-23 Glaxo Group Ltd Nucleosídeos de benzimidazol modificados como agentes antivirais
WO1999006424A1 (en) 1997-07-30 1999-02-11 The Regents Of The University Of Michigan Lyxofuranosyl benzimidazoles as antiviral agents
JP3256513B2 (ja) 1998-02-11 2002-02-12 ファイザー製薬株式会社 ベンゾイミダゾールシクロオキシゲナーゼ−２阻害剤
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
WO2012070069A2 (en) * 2010-11-24 2012-05-31 Sequent Scientific Limited A process for preparation of albendazole
WO2024081308A1 (en) * 2022-10-12 2024-04-18 Takeda Pharmaceutical Company Limited Method of preparing maribavir

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399987A (en) 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
FR2551442B1 (fr) 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
EP0304624A3 (de) 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen
IT1226100B (it) 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1992018517A1 (en) 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
ZA923640B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (en) * 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
US5399580A (en) 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
SK29197A3 (en) 1994-09-09 1997-10-08 Wellcome Found Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring, preparation method thereof, pharmaceutical composition and use
DE69624827T2 (de) 1995-08-18 2003-09-04 Univ Michigan Ann Arbor 5'-substitutierte-ribofuranosyl benzimidazolen als antivirale.
GB9600142D0 (en) 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
BR9707185A (pt) 1996-01-23 1999-03-23 Glaxo Group Ltd Nucleosídeos de benzimidazol modificados como agentes antivirais

Also Published As

Publication number Publication date
EP0970100A1 (de) 2000-01-12
EP0970100B1 (de) 2003-11-12
JP2001512453A (ja) 2001-08-21
CA2280761A1 (en) 1998-08-20
US6413938B1 (en) 2002-07-02
WO1998035977A1 (en) 1998-08-20
DE69819695D1 (en) 2003-12-18
AU6221998A (en) 1998-09-08

Similar Documents

Publication Publication Date Title
HK1046639A1 (en) Nitroimidazole external preparations for dermatosis
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
YU51400A (sh) Derivati 2-piridilmetilamina, kao korisni fungicidi
ES2187473T3 (es) Triarylimidazoles.
MY132872A (en) Benzimidazole derivatives.
DE59108530D1 (de) Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
ATE275134T1 (de) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
DE69325454T2 (de) Taxol-derivate
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DK0449216T3 (da) 3,5-Di-tertiærbutyl-4-hydroxyphenylmethylenderivater af 2-substituerede thiazolidinoner, oxazolidinoner og imidazolidinoner som antiinflammatoriske midler
NO970174L (no) 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner
MX9800577A (es) Derivados de 4,5-diaril oxazol.
HUP9903707A2 (hu) 17Béta-karboxi-,-tio-karboxi-vagy -amido-androsztánszármazékok laktonszármazékai, előállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
LU92263I2 (fr) Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION)
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
ATE254131T1 (de) Benzimidazolderivate
ATE234818T1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
TR200100133T2 (tr) FKBP İnhibitörleri
BR0109276A (pt) Derivados de 1,4-diamino-2-alquenil-benzeno e agentes de tingimento que contêm esses compostos
AU4609701A (en) Colouring agent for keratin containing fibres
NO994104L (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
BR0210201A (pt) Composição
TW282458B (de)
MX9802583A (es) Derivados de fenantridina, procedimiento para su preparacion y medicamentos que contienen derivadosde fenantridina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties